Virtus · 2014-12-16 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-07-31 | -$783,826 | — | — | $96.7M | 每日估算 |
| 2026-07-30 | +$1.4M | — | — | $97.7M | 每日估算 |
| 2026-07-29 | +$435,866 | — | — | $97.3M | 每日估算 |
| 2026-07-28 | +$9.6M | — | — | $96.4M | 每日估算 |
| 2026-07-27 | -$9.6M | — | — | $86.8M |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
IBRX IMMUNITYBIO INC COM | EC | 401,005 | $2.8M | 4.80% |
DGCXX DREYFUS GOVERNMENT CASH MANAGE | STIV | 1,868,134 | $1.9M | 3.15% |
APLS APELLIS PHARMACEUTICALS INC COM | EC | 37,509 | $1.5M | 2.59% |
KALV KALVISTA PHARMACEUTICALS INC COM |
行情与风险截至 2026-07-30；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、nasdaq_etf_summary、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified。
| 每日估算 |
| 2026-07-26 | +$869,003 | — | — | $97.3M | 每日估算 |
| 2026-07-25 | +$869,003 | — | — | $97.3M | 每日估算 |
| 2026-04-30 | +$4.3M | $4.3M | $0 | $59.3M | SEC 月度 |
| 2026-03-31 | +$4.1M | $4.1M | $0 | — | SEC 月度 |
| 2026-02-28 | +$4.1M | $4.1M | $0 | — | SEC 月度 |
| EC |
| 55,964 |
| $1.5M |
| 2.52% |
MRNA MODERNA INC COM | EC | 32,122 | $1.5M | 2.49% |
IOVA IOVANCE BIOTHERAPEUTICS INC COM | EC | 430,167 | $1.4M | 2.44% |
MIRM MIRUM PHARMACEUTICALS INC COM | EC | 14,558 | $1.4M | 2.39% |
AXSM AXSOME THERAPEUTICS INC COM | EC | 6,386 | $1.3M | 2.24% |
KNSA KINIKSA PHARMACEUTICALS INTERNATIONAL PLC ORD SHS CL A | EC | 22,754 | $1.2M | 2.06% |
ROIV ROIVANT SCIENCES LTD SHS | EC | 42,821 | $1.2M | 2.06% |
ZLAB ZAI LAB LTD ADR | EC | 53,256 | $1.2M | 1.94% |
LGND LIGAND PHARMACEUTICALS INC | EC | 4,992 | $1.1M | 1.93% |
BCRX BIOCRYST PHARMACEUTICALS INC COM | EC | 125,015 | $1.1M | 1.93% |
TVTX TRAVERE THERAPEUTICS INC COM | EC | 27,170 | $1.1M | 1.93% |
NVAX NOVAVAX INC COM NEW | EC | 144,044 | $1.1M | 1.93% |
UTHR UNITED THERAPEUTICS CORP | EC | 1,914 | $1.1M | 1.84% |
GERN GERON CORP COM | EC | 695,861 | $1.1M | 1.81% |
BNTX BIONTECH SE SPONSORED ADS | EC | 9,981 | $1.0M | 1.74% |
AMGN AMGEN INC COM | EC | 2,977 | $1.0M | 1.74% |
EXEL EXELIXIS INC | EC | 23,148 | $1.0M | 1.74% |
BIIB BIOGEN INC | EC | 5,434 | $1.0M | 1.73% |
GILD GILEAD SCIENCES INC | EC | 7,859 | $1.0M | 1.73% |
TGTX TG THERAPEUTICS INC COM | EC | 30,187 | $1.0M | 1.72% |
KRYS KRYSTAL BIOTECH INC COM | EC | 3,866 | $1.0M | 1.71% |
LEGN LEGEND BIOTECH CORP SPONSORED ADS | EC | 42,398 | $997,201 | 1.68% |
SNDX SYNDAX PHARMACEUTICALS INC COM | EC | 46,457 | $995,574 | 1.68% |
ARWR ARROWHEAD PHARMACEUTICALS INC COM | EC | 13,501 | $992,053 | 1.67% |
ASND ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS | EC | 4,293 | $984,728 | 1.66% |
AGIO AGIOS PHARMACEUTICALS INC | EC | 34,703 | $971,684 | 1.64% |
HALO HALOZYME THERAPEUTICS INC | EC | 15,211 | $968,332 | 1.63% |
ARDX ARDELYX INC COM | EC | 152,393 | $964,648 | 1.63% |
BMRN BIOMARIN PHARMACEUTICAL INC | EC | 17,750 | $956,903 | 1.61% |
INCY INCYTE CORP | EC | 9,918 | $944,888 | 1.59% |
AUPH AURINIA PHARMACEUTICALS INC COM | EC | 59,707 | $918,592 | 1.55% |
SRPT SAREPTA THERAPEUTICS INC | EC | 43,955 | $917,780 | 1.55% |
REGN REGENERON PHARMACEUTICALS INC | EC | 1,276 | $902,209 | 1.52% |
BBIO BRIDGEBIO PHARMA INC COM | EC | 12,592 | $895,417 | 1.51% |
VRTX VERTEX PHARMACEUTICALS INC | EC | 2,093 | $894,506 | 1.51% |
ONC BEONE MEDICINES LTD SPONSORED ADS | EC | 2,965 | $875,476 | 1.48% |
IONS IONIS PHARMACEUTICALS INC | EC | 11,708 | $875,290 | 1.48% |
CRSP CRISPR THERAPEUTICS AG NAMEN AKT | EC | 16,695 | $873,816 | 1.47% |
TBPH THERAVANCE BIOPHARMA INC | EC | 52,082 | $871,853 | 1.47% |
MDGL MADRIGAL PHARMACEUTICALS INC COM | EC | 1,655 | $856,280 | 1.44% |
KURA KURA ONCOLOGY INC COM | EC | 92,599 | $817,649 | 1.38% |
NBIX NEUROCRINE BIOSCIENCES INC | EC | 6,192 | $815,301 | 1.38% |
PTCT PTC THERAPEUTICS INC COM | EC | 12,510 | $813,901 | 1.37% |
ACAD ACADIA PHARMACEUTICALS INC COM | EC | 34,855 | $782,495 | 1.32% |
ARQT ARCUTIS BIOTHERAPEUTICS INC COM | EC | 32,610 | $757,204 | 1.28% |
TARS TARSUS PHARMACEUTICALS INC COM | EC | 11,632 | $739,912 | 1.25% |
ALNY ALNYLAM PHARMACEUTICALS INC COM | EC | 2,379 | $736,277 | 1.24% |
HRMY HARMONY BIOSCIENCES HOLDINGS INC COM | EC | 23,360 | $730,234 | 1.23% |
PHAT PHATHOM PHARMACEUTICALS INC COM | EC | 64,997 | $727,966 | 1.23% |
CRNX CRINETICS PHARMACEUTICALS INC COM | EC | 18,743 | $726,854 | 1.23% |
IMCR IMMUNOCORE HOLDINGS PLC ADS | EC | 25,714 | $717,678 | 1.21% |
RYTM RHYTHM PHARMACEUTICALS INC COM | EC | 8,333 | $677,973 | 1.14% |
INSM INSMED INC COM PAR $.01 | EC | 4,801 | $654,520 | 1.10% |
RARE ULTRAGENYX PHARMACEUTICAL INC | EC | 26,120 | $644,903 | 1.09% |
NUVB NUVATION BIO INC COM CL A | EC | 112,261 | $499,561 | 0.84% |
ESPR ESPERION THERAPEUTICS INC COM | EC | 245,810 | $491,620 | 0.83% |
ADMA ADMA BIOLOGICS INC COM | EC | 47,844 | $490,401 | 0.83% |
LENZ LENZ THERAPEUTICS INC COM | EC | 52,170 | $468,487 | 0.79% |
2200963D OMNIAB INC USD0.0001 A (USD12.5 VESTING) | EC | 1,295 | $0 | 0.00% |
2200964D OMNIAB INC USD0.0001 A (USD15 VESTING) | EC | 1,295 | $0 | 0.00% |